ushing’s syndrome market is projected to increase due to rise in its awareness and healthcare expenditure
Rise in cortisol hormone fuels the growth of Cushing’s syndrome market
Hormonal disorder caused due to prolonged exposure of body’s tissue to high levels of hormone cortisol leads to Cushing’s syndrome, also called hypercortisolism. Adults aged in the age group of 20-50 years suffer from Cushing’s syndrome. It is rarely seen, though has risk of development in patient who are obese and also have type 2 diabetes, high blood pressure with poorly controlled blood glucose. Cushing’s syndrome market is projected to increase due to rise in its awareness and healthcare expenditure. Various new drugs are available in market due to increase in research and development such as ketoconazole, metyrapone and mitotane to minimize the surgical risk of patient. According to Orphanet Journal of Rare Disease, incidence of Cushi_ng’s syndrome is estimated to be equal to 1–3 cases per million inhabitants per year, whereas its prevalence is close to 40 cases per million inhabitants in 2012.
To understand Research Methodology, please click: https://www.coherentmarketinsights.com/insight/request-sample/554
Regional growth engines that supports Cushing’s syndrome market
In terms of geography Cushing’s syndrome is segmented into North America, Europe, Asia-pacific, Middle East, Latin America and Africa. Due to presence of high income standard and health awareness in North America favors the growth of Cushing’s syndrome market. According to Centers for Disease Control and Prevention more than one-third of the U.S. adults have obesity which is a leading cause to Cushing’s syndrome that was 36.5% during 2011-2014. Furthermore, according to American Diabetes Association type 2 diabetes is most commonly seen in African Americans, Latin Americans and Asia Pacific Islanders.
Cushing’s syndrome is a collection of symptoms and signs, which includes high blood pressure, reddish stretch marks, abdominal obesity, round red face, weak muscles, weak bones, a fat lump between the shoulders and fragile skin that heals slowly due to prolonged exposure to cortisol. Excessive cortisol-like medication such as prednisone or tumor that is produced due to excess cortisol by adrenal glands are the two basic factors that cause Cushing’s syndrome. Other tumors may also cause this disease, which are associated with inherited disorders such as multiple endocrine neoplasia type 1 and Carney complex. Most cases can be treated and cured by combination of surgery radiation or chemotherapy.
Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/554
The most significant cause of Cushing’s syndrome is intake of glucocorticoids prescribed by a healthcare professional to cure other diseases such as asthma, rheumatoid arthritis or in immunosuppression after an organ transplant. Administration of synthetic ACTH can also lead to the condition. It may also occur in other animals such as cats, dogs, and horse. All the factors mentioned above are expected to favor the growth of Cushing’s syndrome market.
The key players dominating the global Cushing’s syndrome market
Increase in research and development in 2016, which includes development of clinical trials for RECORLEV for the treatment of endogenous Cushing’s syndrome by Strongbrigde Biopharma plc is expected to create competition and also favor the growth between various manufacture to lead the market. The key players operating in Cushing’s syndrome market include Corcept Therapeutics Inc., HRA Pharma, Strongbridge Biopharma plc. and Novartis AG.
You may be interested
New Study Reveals Link between Toothpaste Ingredient and Colon CancerMohit Joshi - September 22, 2018
Recent study reported that common compound found in soaps and toothpaste called triclosan can potentially increase risk for developing colon inflammation and cancer Study highlighted effect of…
Hormone Replacement Therapy Market – Latest Advancements & Outlook 2018 to 2026, Global Top Players : Novartis, Abbott, Mylan, Merck KgaA, Bayer, Pfizer, Novo Nordisk, QuatRx, Teva Pharma., Amgen, Eli LillyAlex Mathew - September 22, 2018
According to a new market research study titled Hormone Replacement Therapy Market to 2026 Global Analysis and Forecasts by Material Composition, Industries and End Products, The…
Corporate Wellness Market Segmentation Application Technology & Market Analysis Report, Global Top Players : EXOS, Hooper Holmes, Wellness Corporate Solutions, ComPsych, United Health Group, Sodexo, BupaWellnessAlbert R - September 22, 2018
According to a new market research study titled Corporate Wellness Market to 2026 Global Analysis and Forecasts by Material Composition, Industries and End Products, The report…